IVERIC BIO INC's ticker is ISEE and the CUSIP is 46583P102. A total of 194 filers reported holding IVERIC BIO INC in Q2 2022. The put-call ratio across all filers is 0.55 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $2,823,078 | +61.3% | 71,761 | -0.3% | 0.04% | +34.5% |
| Q1 2023 | $1,750,714 | +13.1% | 71,957 | -0.5% | 0.03% | 0.0% |
| Q4 2022 | $1,547,772 | +19.2% | 72,292 | -0.0% | 0.03% | +26.1% |
| Q3 2022 | $1,298,000 | +38.8% | 72,325 | -25.6% | 0.02% | +35.3% |
| Q2 2022 | $935,000 | -69.5% | 97,168 | -46.7% | 0.02% | -39.3% |
| Q1 2022 | $3,069,000 | -0.6% | 182,343 | -1.2% | 0.03% | +55.6% |
| Q4 2021 | $3,086,000 | – | 184,557 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TCG Crossover Management, LLC | 5,141,118 | $110,071,336 | 19.43% |
| Deep Track Capital, LP | 7,878,119 | $168,670,528 | 7.08% |
| Soleus Capital Management, L.P. | 2,114,728 | $45,276,326 | 6.50% |
| MPM BioImpact LLC | 1,059,688 | $22,687,920 | 5.89% |
| Finepoint Capital LP | 707,600 | $15,150 | 4.90% |
| ACUTA CAPITAL PARTNERS, LLC | 360,500 | $7,718,305 | 4.75% |
| Octagon Capital Advisors LP | 1,278,000 | $27,361,980 | 4.26% |
| Artia Global Partners LP | 504,615 | $10,803,807 | 4.12% |
| Ghost Tree Capital, LLC | 450,000 | $9,635,000 | 4.11% |
| Redmile Group, LLC | 4,502,111 | $96,390,197 | 3.94% |